BIRD ROCK BIO

bird-rock-bio-logo

Bird Rock Bio is focused on the discovery and development of novel biologic therapeutics that meet the medical and commercial needs for China’s patients and healthcare system and that have the potential to be disruptive globally. RYI-008 is a novel, extremely potent monoclonal antibody that is highly selective to IL-6, a cytokine widely implicated in inflammation and cancer. In addition to RYI-008, RuiYi has a growing pipeline of monoclonal antibodies from its internal discovery efforts utiliz... ing a series of the Company’s technologies, including the iCAP (intramembranous Conformation Antigen Presenting) system. Targets include a select subset of G protein coupled receptors (GPCR), where specificity in binding is critical but has proven difficult to achieve with small molecule modulators.

#SimilarOrganizations #People #Financial #Website #More

BIRD ROCK BIO

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2002-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.birdrockbio.com

Total Employee:
11+

Status:
Active

Contact:
(858)587-4815

Email Addresses:
[email protected]

Total Funding:
77.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins


Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

civitas-therapeutics-logo

Civitas Therapeutics

Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.


Current Advisors List

simeon-george_image

Simeon George Board of Directors @ Bird Rock Bio
Board_member

bradley-bolzon_image

Bradley Bolzon Board of Directors @ Bird Rock Bio
Board_member

allan-p-marchington_image

Allan P. Marchington Board of Director @ Bird Rock Bio
Board_member

richard-j-ulevitch_image

Richard J. Ulevitch Scientific Advisory Board @ Bird Rock Bio
Advisor

raymond-e-stevens_image

Raymond E. Stevens Board of Director @ Bird Rock Bio
Board_member

simon-nebel_image

Simon Nebel Member of the Board of Directors @ Bird Rock Bio
Board_member

paul-grayson_image

Paul Grayson Board of Directors @ Bird Rock Bio
Board_member

peppi-prasit_image

Peppi Prasit Board of Director @ Bird Rock Bio
Board_member

Current Employees Featured

paul-grayson_image

Paul Grayson
Paul Grayson President and CEO @ Bird Rock Bio
President and CEO
2011-06-01

erik-karrer_image

Erik Karrer
Erik Karrer CSO @ Bird Rock Bio
CSO

chris-song_image

Chris Song
Chris Song Senior Director of Operations @ Bird Rock Bio
Senior Director of Operations

anke-kretz-rommel_image

Anke Kretz-Rommel
Anke Kretz-Rommel Chief Technology Officer @ Bird Rock Bio
Chief Technology Officer
2015-03-01

teddy-yang_image

Teddy Yang
Teddy Yang Director of Pharmacology @ Bird Rock Bio
Director of Pharmacology

lei-shi_image

Lei Shi
Lei Shi Director of Antibody Discovery @ Bird Rock Bio
Director of Antibody Discovery

Founder


raymond-e-stevens_image

Raymond E. Stevens

Investors List

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Bird Rock Bio

merckventures_image

M Ventures

M Ventures investment in Series B - Bird Rock Bio

apposite-capital_image

Apposite Capital

Apposite Capital investment in Series B - Bird Rock Bio

sr-one_image

SR One

SR One investment in Series B - Bird Rock Bio

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - Bird Rock Bio

aravis-ventures_image

Aravis Ventures

Aravis Ventures investment in Series B - Bird Rock Bio

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series B - Bird Rock Bio

sr-one_image

SR One

SR One investment in Series A - Bird Rock Bio

merckventures_image

M Ventures

M Ventures investment in Series A - Bird Rock Bio

aravis-ventures_image

Aravis Ventures

Aravis Ventures investment in Series A - Bird Rock Bio

Official Site Inspections

http://www.birdrockbio.com Semrush global rank: 5.87 M Semrush visits lastest month: 1.41 K

  • Host name: canescredit.com
  • IP address: 208.97.145.221
  • Location: Brea United States
  • Latitude: 33.9339
  • Longitude: -117.8854
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 92821

Loading ...

More informations about "Bird Rock Bio"

Bird Rock Bio - Crunchbase Company Profile & Funding

Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators. Bird Rock Bio may be growing as evidenced by recent strategic developments.See details»

Bird Rock Bio, Inc. | LinkedIn

Backed by leading biotechnology venture investors, our strategy leverages biologic targets with substantial human proof of mechanism for the development of novel, best in class therapeutic...See details»

Bird Rock Bio - VentureRadar

Bird Rock Bio is a clinical-stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators. We are developing first-in-class, best-in-class therapeutic …See details»

Bird Rock Bio - PitchBook

Mar 22, 2012 · Developer of therapeutic antibodies intended to advance the discovery and development of biologic therapeutics.See details»

Skye Completes $17M Financing and Acquires Novel Phase 2 …

Aug 21, 2023 · Skye raised $17M in new capital and acquired Bird Rock Bio Inc. ("Bird Rock"). With Bird Rock's lead asset, nimacimab, Skye intends to advance two complementary but …See details»

Skye Completes $17M Financing and Acquires Novel …

Aug 21, 2023 · Acquisition of Bird Rock Bio builds Skye's position as a leading endocannabinoid system-focused pharmaceutical company. New capital funds anticipated Phase 2a glaucoma clinical trial; Nimacimab is a first-in-class …See details»

Bird Rock Bio Announces Corporate Name Change …

Dec 14, 2015 · Change reflects evolution from discovery research to global clinical development company focused on developing innovative immuno-inflammatory regulators. Bird Rock Bio, Inc., a clinical stage …See details»

Bird Rock Bio Announces Corporate Name Change from RuiYi, Inc.

Dec 14, 2015 · Bird Rock Bio believes gerilimzumab has the potential to effectively compete in the $35 billion global biologic market for rheumatoid arthritis by not only treating the large number …See details»

Bird Rock Bio - Craft

See insights on Bird Rock Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Bird Rock Bio, Inc. Company Profile | San Diego, CA | Competitors ...

Find company research, competitor information, contact details & financial data for Bird Rock Bio, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

Bird Rock Bio | San Diego CA - Facebook

Bird Rock Bio, San Diego, California. 31 likes · 2 were here. Bird Rock Bio is a clinical stage biotech company focused on developing innovative immuno-inflammatory regulators.See details»

Skye Bioscience : Acquisition of Bird Rock Bio builds Skye’s …

Aug 21, 2023 · Acquisition of Bird Rock Bio builds Skye's position as a leading endocannabinoid system-focused pharmaceutical company. •New capital funds anticipated Phase 2a glaucoma …See details»

Bird Rock Bio Announces Successful Completion of Phase 1B …

Oct 17, 2019 · Backed by leading biotechnology venture investors, Bird Rock Bio's strategy leverages biologic targets with substantial human proof of mechanism for the development of …See details»

Skye Completes $17M Financing and Acquires Novel Phase 2

Aug 21, 2023 · Skye raised $17M in new capital and acquired Bird Rock Bio Inc. (“Bird Rock”). With Bird Rock’s lead asset, nimacimab, Skye intends to advance two complementary but …See details»

Bird Rock one step closer to acquisition by J&J | BioPharma Dive

Jan 12, 2017 · Just a week after giving exclusive acquisition rights to Johnson & Johnson, clinical-stage biopharma Bird Rock Bio took the first step to that end, announcing the approval of …See details»

Bird Rock Bio Submits Clinical Trial Authorization for the First in ...

LA JOLLA, Calif., Oct. 27, 2016 /PRNewswire/ -- Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, announced that today it has requested approval for the initiation …See details»

Bird Rock Bio's Gerilimzumab, an Anti-IL-6 Antibody, …

LA JOLLA, Calif., March 16, 2016 /PRNewswire/ -- Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, today announced positive results from two clinical studies …See details»

Bird Rock Bio receives approval to start first in human clinical trial ...

Jan 11, 2017 · * Bird Rock Bio says has received approval for initiation of a two-part phase 1 clinical trial for Namacizumab. * Bird Rock Bio says entered into agreement with GE …See details»

Bird Rock Bio Receives Approval to Start First in Human Clinical …

LA JOLLA, Calif., Jan. 11, 2017 /PRNewswire/ -- Bird Rock Bio, Inc. a clinical stage biopharmaceutical company, announced today that it has received approval for the initiation of …See details»

Bird Rock Bio Files IND Application for Phase 2 Study of …

May 28, 2020 · Bird Rock Bio owns the worldwide rights to nimacimab, with patents issued in the U.S. and other territories, including claims to cannabinoid 1 receptor antibodies with inverse …See details»

linkstock.net © 2022. All rights reserved